May 31, 2023

Press release - Non-regulatory

Circio invites to a company update on Thursday 15 June 2023

May 26, 2023

Press release - Regulatory

Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds

May 25, 2023

Press release - Regulatory

Circio Holding ASA – New name registered

May 23, 2023

Press release - Regulatory

Circio Holding ASA: Requested Conversion of Convertible Bonds

May 22, 2023

Press release - Regulatory

Targovax ASA: Minutes from the Annual General Meeting

May 16, 2023

Press release - Non-regulatory

Circio: Link to recording and presentation from Company update 16[th] May 2023

May 12, 2023

Press release - Regulatory

Circio invites to a company update on Tuesday 16 May 2023

May 3, 2023

Press release - Regulatory

Targovax ASA – Correction of the proxy form attached to the notice of the Annual General Meeting

May 3, 2023

Press release - Non-regulatory

Circio: circRNA poster to be presented at the ASGCT Annual Meeting

April 28, 2023

Press release - Regulatory

Targovax ASA – Notice of Annual General Meeting

April 19, 2023

Press release - Regulatory

Targovax to rebrand as Circio, an innovator in next generation circular RNA therapeutics

April 13, 2023

Press release - Regulatory

Targovax ASA: Annual Report 2022

April 13, 2023

Press release - Non-regulatory

Targovax ASA: Registration of share capital increase following conversion of convertible bonds

April 13, 2023

Press release - Non-regulatory

Financial calendar

March 30, 2023

Press release - Non-regulatory

Targovax ASA: Requested Conversion of Convertible Bonds

March 15, 2023

Press release - Non-regulatory

Targovax ASA: circRNA poster to be presented at the AACR Annual Meeting

March 14, 2023

Press release - Non-regulatory

Targovax: First patient dosed with TG01 in the USA

March 9, 2023

Press release - Regulatory

Targovax ASA – First Tranche of Convertible Bonds

March 9, 2023

Press release - Regulatory

Targovax ASA: Minutes from the Extraordinary General Meeting

March 7, 2023

Press release - Regulatory

Targovax to prioritize resources on unlocking the potential of its circRNA platform

March 6, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

March 6, 2023

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

March 2, 2023

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

March 2, 2023

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

March 1, 2023

Press release - Regulatory

Targovax ASA – Additional information prior to the Extraordinary General Meeting

February 23, 2023

Press release - Regulatory

Targovax invites to Q&A webcast regarding convertible bond financing

February 16, 2023

Press release - Regulatory

Targovax ASA – Notice of Extraordinary General Meeting

February 16, 2023

Press release - Regulatory

Targovax ASA: Fourth quarter 2022 results

February 16, 2023

Press release - Regulatory

Targovax announces financing of up to NOK 300m over three years to advance its clinical cancer programs & pre-clinical circular RNA platform

February 8, 2023

Press release - Regulatory

Targovax ASA: Invitation to Targovax’s fourth quarter 2022 presentation, Thursday 16 February

December 22, 2022

Press release - Non-regulatory

Targovax announces that the TG01 study in multiple myeloma at Oslo University Hospital has received regulatory approvals to proceed

December 20, 2022

Press release - Regulatory

Targovax ASA issues options to employees

December 15, 2022

Press release - Non-regulatory

Targovax announces clinical trial collaboration with Agenus to test TG mutant RAS vaccination in pancreatic cancer

December 7, 2022

Press release - Non-regulatory

Targovax to present and attend at upcoming conferences

November 10, 2022

Press release - Non-regulatory

Hubro Therapeutics AS acquires GM-CSF vaccine adjuvant from Targovax ASA in asset purchase agreement

November 3, 2022

Press release - Regulatory

Targovax ASA: Third quarter 2022 results

October 26, 2022

Press release - Regulatory

Invitation to Targovax’s third quarter 2022 presentation, Thursday 3 November

October 20, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research – with updated publication info

October 20, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study is published in the prestigious scientific journal Clinical Cancer Research

October 5, 2022

Press release - Non-regulatory

The ONCOS-102 phase 1b melanoma study selected for oral presentation at the SITC 2022 annual meeting

September 27, 2022

Press release - Non-regulatory

Targovax receives approval to proceed with the ONCOS-102 phase 2 melanoma study from the US FDA

September 26, 2022

Press release - Non-regulatory

Reminder: Targovax to host Investor Event 27 September

September 19, 2022

Press release - Non-regulatory

Targovax to host Investor Event: Meet the Management on 27 September

September 12, 2022

Press release - Non-regulatory

Targovax to present at upcoming conferences

August 18, 2022

Press release - Regulatory

Targovax ASA: Second quarter and first half year 2022 results

August 11, 2022

Press release - Non-regulatory

Targovax ASA: Invitation to Targovax’s second quarter and first half 2022 presentation, Thursday 18 August

July 4, 2022

Press release - Regulatory

Targovax: Completion of drop-down demerger

June 23, 2022

Press release - Non-regulatory

Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA

June 23, 2022

Press release - Non-regulatory

Targovax: FDA gir tillatelse til å starte kliniske studier med ny og forbedret TG01 kreftvaksine i USA

June 7, 2022

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units and exercise of employee options

May 31, 2022

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs

May 31, 2022

Press release - Regulatory

Targovax ASA: Exercise of options, settlement of restricted stock units and resolutions to increase the share capital

May 27, 2022

Press release - Non-regulatory

Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022

May 12, 2022

Press release - Regulatory

Targovax ASA: First quarter 2022 results

May 11, 2022

Press release - Regulatory

Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial

May 11, 2022

Press release - Non-regulatory

Targovax to present at upcoming conferences

May 10, 2022

Press release - Non-regulatory

Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma

May 3, 2022

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May

April 28, 2022

Press release - Non-regulatory

Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO

April 26, 2022

Press release - Non-regulatory

Targovax to present at 5th Neoantigen Summit Europe in Amsterdam

April 21, 2022

Press release - Non-regulatory

Targovax ASA announces the appointment of two new Board Directors

April 20, 2022

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 20, 2022

Press release - Regulatory

Targovax ASA: Minutes from the Annual General Meeting

March 30, 2022

Press release - Regulatory

Notice of Annual General Meeting

March 14, 2022

Press release - Regulatory

Targovax – Proposal to implement a drop-down demerger

March 9, 2022

Press release - Regulatory

Targovax ASA: Annual Report 2021

March 9, 2022

Press release - Non-regulatory

Targovax ASA: Poster presentation at the AACR Annual Meeting

March 8, 2022

Press release - Regulatory

Targovax ASA: Registration of share capital increases following exercise of options

March 7, 2022

Press release - Regulatory

Targovax ASA: GRANT OF SHARE OPTIONS TO NEW CFO

March 7, 2022

Press release - Non-regulatory

Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™

March 2, 2022

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

March 2, 2022

Press release - Regulatory

Targovax ASA: Exercise of options under LTI program, settlement of RSUs and resolution to increase the share capital

February 28, 2022

Press release - Regulatory

Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer

February 17, 2022

Press release - Regulatory

Targovax ASA: Fourth quarter 2021 results

February 9, 2022

Press release - Regulatory

Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February

February 1, 2022

Press release - Non-regulatory

Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)

February 1, 2022

Press release - Regulatory

Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration

January 17, 2022

Press release - Non-regulatory

Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan

January 12, 2022

Press release - Regulatory

Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway

December 23, 2021

Press release - Regulatory

Targovax ASA issues options to employees

December 22, 2021

Press release - Regulatory

Targovax ASA – Registration of share capital increase pertaining to the Rights Issue

December 20, 2021

Press release - Non-regulatory

Targovax ASA: ONCOS-102 achieves 25.0 months median overall survival in first line mesothelioma

December 16, 2021

Press release - Regulatory

Targovax ASA: Primary insider share purchase

December 16, 2021

Press release - Regulatory

Targovax ASA: Primary insiders share purchase

December 16, 2021

Press release - Regulatory

Targovax ASA: Primary insiders share purchase

December 15, 2021

Press release - Regulatory

Targovax awarded NOK 9.8m research grant by the Research Council of Norway towards the TG mutant RAS program

December 15, 2021

Press release - Regulatory

Targovax ASA – Final results of the rights issue

December 14, 2021

Press release - Regulatory

Targovax ASA – Preliminary results of the rights issue

December 14, 2021

Press release - Regulatory

Targovax ASA – The subscription period for the rights issue expires today

December 13, 2021

Press release - Non-regulatory

Targovax to present at DNB’s 12[th] Nordic Healthcare Conference

December 10, 2021

Press release - Regulatory

Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

December 10, 2021

Press release - Regulatory

Targovax ASA – Last day of trading in subscription rights

December 10, 2021

Press release - Regulatory

Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

December 5, 2021

Press release - Regulatory

Shareholder disclosure by Radforsk Investeringsstiftelse

December 1, 2021

Press release - Regulatory

Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

November 30, 2021

Press release - Regulatory

Targovax ASA – Exercise of subscription rights in the rights issue by close associate of a primary insider

November 30, 2021

Press release - Regulatory

Targovax ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates

November 30, 2021

Press release - Regulatory

Targovax ASA – Commencement of the subscription period for the rights issue

November 29, 2021

Press release - Regulatory

Targovax ASA – Approval and publication of the prospectus for the rights issue

November 26, 2021

Press release - Regulatory

TRVX – Ex. subscription rights today

November 25, 2021

Press release - Regulatory

Targovax ASA – Rights issue approved by the extraordinary general meeting

November 24, 2021

Press release - Regulatory

Targovax ASA – Updated key information relating to the preferential rights issue

November 24, 2021

Press release - Regulatory

Targovax ASA – Terms of the fully underwritten rights issue

November 18, 2021

Press release - Non-regulatory

Targovax invites to webcast presentation in Norwegian

November 9, 2021

Press release - Non-regulatory

Targovax announces two posters at the 2021 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 4, 2021

Press release - Regulatory

Targovax ASA – Key information relating to the preferential rights issue

November 4, 2021

Press release - Regulatory

Targovax ASA – Notice of extraordinary general meeting – Fully underwritten rights issue

November 4, 2021

Press release - Regulatory

Targovax ASA: Third quarter 2021 results

October 27, 2021

Press release - Regulatory

Targovax ASA: PDMR notices

October 27, 2021

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s third quarter 2021 results, Thursday 4 November

October 25, 2021

Press release - Non-regulatory

Targovax: Presentation material for today’s webcast

October 22, 2021

Press release - Non-regulatory

Targovax invites to webcast presentation on Xtrainvestor

October 21, 2021

Press release - Regulatory

Targovax ASA: GRANT OF SHARE OPTIONS

October 20, 2021

Press release - Regulatory

Targovax ASA appoints Dr. Erik Digman Wiklund as new CEO

October 19, 2021

Press release - Non-regulatory

Targovax to present at upcoming conferences

October 6, 2021

Press release - Non-regulatory

Targovax ASA: Two abstracts accepted at the SITC Congress

October 3, 2021

Press release - Regulatory

Targovax ASA issues options to new member of management

September 30, 2021

Press release - Non-regulatory

Targovax ASA appoints Ola Melin as Head of Manufacturing

September 24, 2021

Press release - Non-regulatory

Targovax granted European Patent for ONCOS-102 in combination with chemotherapy

September 16, 2021

Press release - Non-regulatory

Targovax ASA: Poster at European Society for Medical Oncology (ESMO)

August 27, 2021

Press release - Non-regulatory

Targovax ASA: Abstract on ONCOS-102 phase 1 trial in advanced PD1 refractory melanoma is accepted at ESMO Congress

August 18, 2021

Press release - Regulatory

Targovax ASA: second quarter and first half year 2021 results

August 16, 2021

Press release - Non-regulatory

Targovax to present at upcoming scientific conferences

August 9, 2021

Press release - Regulatory

Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2021 results, Wednesday 18 August

July 9, 2021

Press release - Regulatory

Targovax announces resignation of Chief Financial Officer, Torbjørn Furuseth

July 2, 2021

Press release - Regulatory

Targovax ASA issues options to new member of management

July 1, 2021

Press release - Regulatory

Targovax ASA appoints Dr Lone Ottesen as Chief Development Officer

June 28, 2021

Press release - Regulatory

Targovax to present at the 4th Annual Next Gen Immuno-Oncology Virtual Congress-US Edition

June 22, 2021

Press release - Regulatory

Targovax receives Fast Track designation for ONCOS-102 in melanoma

June 17, 2021

Press release - Regulatory

Targovax announces completed enrollment in the phase 1/2 trial with ONCOS-102 in combination with durvalumab in patients with advanced colorectal cancer with peritoneal malignancies

June 14, 2021

Press release - Regulatory

Targovax releases presentations of ONCOS-102 mesothelioma 24-month data

June 10, 2021

Press release - Regulatory

Targovax’s ONCOS-102 mesothelioma 24-month data shows class-leading median overall survival

May 26, 2021

Press release - Regulatory

Targovax ASA: Registration of share capital increase following the settlement of RSUs

May 21, 2021

Press release - Non-regulatory

Targovax to present at upcoming investor and scientific conferences

May 19, 2021

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

May 18, 2021

Press release - Regulatory

Targovax ASA: Resolution to increase the share capital following exercise of RSUs

May 6, 2021

Press release - Regulatory

Targovax ASA: First quarter 2021 results

April 27, 2021

Press release - Regulatory

Targovax ASA: Invitation to presentation of Targovax’s first quarter 2021 results, Thursday 6 May

March 18, 2021

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

March 17, 2021

Press release - Non-regulatory

Targovax ASA announces new member of the Board

March 17, 2021

Press release - Non-regulatory

Targovax ASA: Minutes from the Annual General Meeting

March 9, 2021

Press release - Non-regulatory

Targovax granted US Patent for ONCOS-102 in combination with checkpoint inhibitors

March 8, 2021

Press release - Non-regulatory

Targovax to present and attend at upcoming investor and scientific conferences

March 4, 2021

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of options

March 1, 2021

Press release - Regulatory

Targovax ASA: Exercise of options under LTI program and resolution to increase the share capital

February 24, 2021

Press release - Non-regulatory

Targovax: Proposal for Remuneration Guidelines for Board and Executive Management

February 23, 2021

Press release - Non-regulatory

Continued survival benefit in Targovax’s ONCOS-102 trial in mesothelioma at the 21-month follow-up

February 18, 2021

Press release - Non-regulatory

Reminder: Invitation to Targovax’s Capital Markets Day 18 February 2021

February 18, 2021

Press release - Regulatory

Targovax ASA: Annual Report 2020

February 18, 2021

Press release - Regulatory

Targovax ASA: Fourth quarter 2020 results

February 17, 2021

Press release - Non-regulatory

Notice of Annual General Meeting

February 15, 2021

Press release - Non-regulatory

Targovax receives Fast-Track designation for ONCOS-102

February 11, 2021

Press release - Non-regulatory

Agenda for Targovax’s Capital Markets Day 18 February 2021

February 10, 2021

Press release - Non-regulatory

Targovax and Papyrus Therapeutics enter research collaboration to develop novel ONCOS viruses with receptor tyrosine kinase (RTK) inhibitor functionality

February 9, 2021

Press release - Non-regulatory

SOTIO has stopped collaboration trial with the dendritic cell vaccine DCVAC in combination with ONCOS-102

January 11, 2021

Press release - Non-regulatory

Targovax to present at the H.C. Wainwright Virtual BioConnect 2021 Conference

January 6, 2021

Press release - Non-regulatory

Targovax grants IOVaxis 3 months extension to the exclusive license option for TG mutant RAS vaccines in Greater China and Singapore

December 23, 2020

Press release - Regulatory

Targovax ASA issues options to employees

December 15, 2020

Press release - Non-regulatory

Targovax ASA: Save the date – Capital Markets Day 2021

December 14, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of options

December 10, 2020

Press release - Non-regulatory

Targovax to present at DNB’s 11[th] Annual Nordic Healthcare Conference

December 8, 2020

Press release - Regulatory

Targovax ASA: Exercise of options and resolution to increase the share capital

December 3, 2020

Press release - Regulatory

Targovax ASA: Primary insider share purchase

December 2, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to online presentation at 10:00 CET 2 December

December 1, 2020

Press release - Non-regulatory

Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients

November 24, 2020

Press release - Non-regulatory

Targovax demonstrates encouraging survival data for ONCOS-102 in mesothelioma

November 17, 2020

Press release - Non-regulatory

Targovax to present at Bryan Garnier & Co Virtual European Healthcare Conference

November 9, 2020

Press release - Non-regulatory

Targovax announces poster at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

November 5, 2020

Press release - Non-regulatory

Targovax ASA: third quarter 2020 results

November 2, 2020

Press release - Non-regulatory

Targovax to present at the World Immunotherapy Congress

October 28, 2020

Press release - Non-regulatory

Targovax announces formation of new Scientific Advisory Board

October 26, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s third quarter 2020 results, Thursday 5 November

October 22, 2020

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

October 20, 2020

Press release - Regulatory

TARGOVAX ASA – NO SUBSEQUENT OFFERING

October 19, 2020

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

October 19, 2020

Press release - Non-regulatory

Targovax announces accepted abstract at SITC

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

October 14, 2020

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

October 13, 2020

Press release - Non-regulatory

Targovax announces that the ONCOS-102 and durvalumab trial successfully completes part 1 in colorectal cancer

October 12, 2020

Press release - Non-regulatory

Targovax granted European Patent for ONCOS-102 in combination with checkpoint inhibitors

September 18, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

September 14, 2020

Press release - Non-regulatory

Targovax is invited to present at H.C. Wainwright 22[nd] Annual Global Investment Conference

September 2, 2020

Press release - Non-regulatory

Targovax is invited to present at Pareto Nordic Healthcare conference and RAS-targeted drug development summit

August 31, 2020

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units by primary insider and resolution to increase the share capital

August 20, 2020

Press release - Regulatory

Targovax ASA: second quarter and first half 2020 results

August 12, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s second quarter and first half 2020 results, Thursday 20 August

June 29, 2020

Press release - Non-regulatory

Targovax and Oblique enter collaboration to target mutant RAS cancers by combining their ONCOS and Abiprot™ platforms

June 24, 2020

Press release - Non-regulatory

Targovax announces presentation of pre-clinical data from Next Generation ONCOS at AACR Virtual Annual Conference

June 23, 2020

Press release - Non-regulatory

Targovax announces collaboration to evaluate ONCOS-102 in combination with KEYTRUDA® in mesothelioma

June 22, 2020

Press release - Non-regulatory

Targovax to present at the upcoming 2020 Virtual European Biotech Investor Day 2020

June 22, 2020

Press release - Non-regulatory

Targovax’s ONCOS-102 mesothelioma 12-month data powerfully demonstrate broad immune activation linked to clinical benefit

June 4, 2020

Press release - Non-regulatory

Targovax enters collaboration with Leidos to add checkpoint inhibitor functionality to ONCOS viruses

May 14, 2020

Press release - Non-regulatory

Targovax announces that the ONCOS-102 and durvalumab abstract is selected for a Poster Discussion Session at ASCO

May 7, 2020

Press release - Regulatory

Targovax ASA: First quarter 2020 results

May 6, 2020

Press release - Non-regulatory

Targovax announces that abstract on interim phase I clinical data from the phase I/II peritoneal trial is accepted at ASCO

May 5, 2020

Press release - Regulatory

Targovax ASA issues options to new member of management

May 4, 2020

Press release - Non-regulatory

Targovax releases update for mesothelioma trial combining ONCOS-102 and chemotherapy

April 30, 2020

Press release - Non-regulatory

Targovax ASA appoints Dr Victor Levitsky as Chief Scientific Officer

April 30, 2020

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 29, 2020

Press release - Non-regulatory

Targovax ASA: Minutes from the Annual General Meeting

April 29, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to online presentation of Targovax’s first quarter 2020 results, Thursday 7 May

April 22, 2020

Press release - Non-regulatory

Targovax and Valo Therapeutics enter collaboration to develop RAS neoantigen coating of ONCOS viruses using PeptiCRAd technology

April 3, 2020

Press release - Non-regulatory

Targovax ASA announces proposed new Chairman of the Board

April 2, 2020

Press release - Non-regulatory

Notice of Annual General Meeting

March 30, 2020

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of restricted stock units

March 26, 2020

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

March 26, 2020

Press release - Non-regulatory

Targovax to present at the 2020 Solebury Trout Virtual Investor Conference today

March 23, 2020

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insiders in connection with settlement of RSUs

March 20, 2020

Press release - Non-regulatory

Impact of corona virus (COVID-19) on Targovax’s operations

March 11, 2020

Press release - Regulatory

Targovax ASA: Fourth quarter 2019 results

March 11, 2020

Press release - Regulatory

Targovax ASA: Annual Report 2019

March 3, 2020

Press release - Non-regulatory

Targovax announces completed enrollment in the ONCOS-102 trial in anti-PD1 refractory melanoma

March 3, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2019 results, Wednesday 11 March

January 31, 2020

Press release - Regulatory

TARGOVAX ASA – NO SUBSEQUENT OFFERING

January 28, 2020

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

January 22, 2020

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

January 22, 2020

Press release - Non-regulatory

Reminder: Targovax ASA – Invitation to investor call

January 21, 2020

Press release - Non-regulatory

Targovax ASA: Invitation to investor call

January 21, 2020

Press release - Non-regulatory

Targovax announces encouraging data in mesothelioma study combining ONCOS-102 and standard of care chemotherapy

January 8, 2020

Press release - Non-regulatory

Targovax and IOVaxis Therapeutics enters Option Agreement for TG mutant RAS vaccine license and clinical development in China

December 19, 2019

Press release - Regulatory

Targovax ASA issues options to employees

November 28, 2019

Press release - Regulatory

Targovax ASA: Primary insider share purchase

November 11, 2019

Press release - Non-regulatory

Presentation of ONCOS-102 melanoma data at SITC Annual Meeting

November 7, 2019

Press release - Regulatory

Targovax ASA: Third quarter 2019 results

October 29, 2019

Press release - Non-regulatory

Targovax ASA: Invitation to presentation of Targovax’s third quarter 2019 results, Thursday 7 November

October 9, 2019

Press release - Non-regulatory

Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting

September 24, 2019

Press release - Non-regulatory

Targovax announces opening of Oslo University Hospital as site for ONCOS-102 trial in melanoma

September 18, 2019

Press release - Regulatory

Correction: Targovax Q2 2019 report

August 22, 2019

Press release - Regulatory

Targovax ASA: Second quarter and first half 2019 results

August 12, 2019

Press release - Non-regulatory

Targovax ASA: Announcement of second quarter and first half results 2019

July 31, 2019

Press release - Non-regulatory

Targovax is invited to present at Solebury Trout European Biotech Investor Day in NYC

July 15, 2019

Press release - Non-regulatory

Targovax announces start of the expansion part in the phase I/II trial with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

July 9, 2019

Press release - Regulatory

Targovax ASA: Notification of trade by primary insiders

July 8, 2019

Press release - Regulatory

Targovax announces encouraging results from part 1 of the ONCOS-102 and Keytruda combination trial in anti-PD1 refractory melanoma

June 18, 2019

Press release - Regulatory

Targovax ASA: Registration of share capital increase following settlement of RSUs

June 13, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider following settlement of RSUs

June 12, 2019

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

June 6, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

June 6, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

June 5, 2019

Press release - Regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

June 3, 2019

Press release - Non-regulatory

Targovax announces publication of in vivo abscopal effect of ONCOS-102 and Keytruda combination

May 31, 2019

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

May 28, 2019

Press release - Regulatory

Targovax ASA: Final result of the subsequent offering

May 24, 2019

Press release - Regulatory

Targovax ASA: Last day of the subscription period in the subsequent offering

May 23, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

May 23, 2019

Press release - Regulatory

Targovax to fully focus on ONCOS oncolytic virus program

May 23, 2019

Press release - Regulatory

Targovax announces median and three-year overall survival for TG01 trial in resected pancreatic cancer

May 10, 2019

Press release - Regulatory

Targovax ASA: Commencement of subscription period in the subsequent offering

May 9, 2019

Press release - Regulatory

Targovax ASA: First quarter 2019 results

May 8, 2019

Press release - Non-regulatory

Targovax announces completed enrollment of ONCOS-102 trial in mesothelioma

May 2, 2019

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 30, 2019

Press release - Regulatory

Targovax ASA: Minutes from the Annual General Meeting

April 30, 2019

Press release - Non-regulatory

Targovax ASA: Announcement of first quarter 2019

April 12, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF SUPPLEMENTAL PROSPECTUS

April 9, 2019

Press release - Regulatory

Targovax ASA: Annual Report 2018

April 9, 2019

Press release - Regulatory

Notice of Annual General Meeting

March 28, 2019

Press release - Regulatory

TARGOVAX ASA – REGISTRATION OF SHARE CAPITAL INCREASE FOLLOWING THE PRIVATE PLACEMENT

March 27, 2019

Press release - Regulatory

TARGOVAX ASA – APPROVAL AND PUBLICATION OF PROSPECTUS

March 25, 2019

Press release - Regulatory

Targovax to hold a webcast with Q&A session

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – NOTIFICATION OF SHAREHOLDING

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – KEY INFORMATION RELATED TO THE SUBSEQUENT OFFERING

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

March 21, 2019

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

March 19, 2019

Press release - Non-regulatory

Targovax is invited to present at Neoantigen Summit Europe, DNB SME Conference and BIO-Europe Spring

March 15, 2019

Press release - Regulatory

Targovax signs clinical collaboration agreement with the Parker Institute for Cancer Immunotherapy and Cancer Research Institute

March 14, 2019

Press release - Non-regulatory

Targovax grants Zelluna Immunotherapy an FTO license to intellectual property relating to mutant RAS T cell receptor technology

March 8, 2019

Press release - Non-regulatory

Targovax announces Notice of Allowance in the US on patent covering the TG mutant-RAS neoantigen vaccine platform

February 14, 2019

Press release - Regulatory

Targovax ASA: Fourth quarter and full year 2018 results

February 11, 2019

Press release - Non-regulatory

First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma

February 4, 2019

Press release - Non-regulatory

Targovax ASA: Announcement of fourth quarter and full year results 2018

January 21, 2019

Press release - Non-regulatory

Targovax is invited to present at upcoming investor conferences

January 17, 2019

Press release - Non-regulatory

Targovax granted European Patent for mutant-RAS neoantigen platform lead products

January 3, 2019

Press release - Regulatory

Targovax ASA issues options to employees

December 12, 2018

Press release - Regulatory

Targovax Presents at DNB 9th Annual Nordic Healthcare Conference

November 28, 2018

Press release - Non-regulatory

Targovax is invited to present at upcoming investor and industry conferences

November 16, 2018

Press release - Non-regulatory

Targovax to present at NeoAg Summit 2018

November 1, 2018

Press release - Regulatory

Targovax ASA: Third quarter 2018 results

October 26, 2018

Press release - Regulatory

Targovax ASA: Announcement of third quarter 2018 financial results

October 15, 2018

Press release - Non-regulatory

Targovax reports encouraging disease-free survival (DFS) data from TG01 trial in resected pancreatic cancer

October 12, 2018

Press release - Regulatory

Agenda for Targovax Capital Markets Day 15 October 2018, in Oslo, Norway

October 11, 2018

Press release - Regulatory

Targovax Key Opinion Leader Symposium on Oncolytic Viruses in New York City today, 11 October, 2018

October 4, 2018

Press release - Regulatory

Targovax to host Capital Markets Day 15 October 2018, in Oslo, Norway

October 1, 2018

Press release - Regulatory

Targovax presented ONCOS-102 poster at 13th International Adenovirus Meeting

September 27, 2018

Press release - Regulatory

Targovax announces interim results from Phase I trial of ONCOS-102 in checkpoint inhibitor refractory melanoma

September 27, 2018

Press release - Regulatory

Targovax to Host Key Opinion Leader Symposium on Oncolytic Viruses in New York City, 11 October 2018

September 25, 2018

Press release - Regulatory

Targovax ASA: Issuance of options to primary insider

September 13, 2018

Press release - Regulatory

Targovax strengthens management team with the appointment of Torbjørn Furuseth as CFO; Erik Digman Wiklund to become CBO

September 12, 2018

Press release - Regulatory

Targovax announces publication of new oncolytic virus data in the Journal of Medical Virology and Cancer Gene Therapy

September 4, 2018

Press release - Regulatory

Targovax ASA: Registration of new share capital following settlement of restricted stock units

August 29, 2018

Press release - Regulatory

Targovax ASA: Settlement of restricted stock units and resolution to increase the share capital

August 23, 2018

Press release - Regulatory

Targovax ASA: Second quarter and first half year 2018 results

August 15, 2018

Press release - Regulatory

Targovax ASA: Invitation to second quarter and first half year 2018 results presentation Thursday 23 August

July 12, 2018

Press release - Regulatory

Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC

June 20, 2018

Press release - Regulatory

Targovax ASA: Mandatory notification of trade – primary insider

June 19, 2018

Press release - Regulatory

Targovax granted EU Patent for mutant-RAS neoantigen platform 2nd generation product TG02

June 12, 2018

Press release - Regulatory

Targovax hosts conference call 12 June 2018

June 11, 2018

Press release - Regulatory

Targovax strengthens focus on ONCOS oncolytic virus development program

June 4, 2018

Press release - Regulatory

Targovax to Present at Jefferies 2018 Global Healthcare Conference

May 24, 2018

Press release - Regulatory

Targovax strengthens 2-year survival rate in resected pancreatic cancer with TG01

May 16, 2018

Press release - Regulatory

Targovax to present at upcoming investor and industry conferences

May 3, 2018

Press release - Regulatory

Targovax ASA: First quarter 2018 results

May 2, 2018

Press release - Regulatory

Targovax announces early signal of efficacy in ONCOS-102 trial in mesothelioma

April 25, 2018

Press release - Regulatory

Targovax ASA: Issuance of restricted stock units (RSUs) to the board members

April 25, 2018

Press release - Non-regulatory

Targovax presentation at ChinaBio Partnering Forum 2018

April 24, 2018

Press release - Regulatory

Targovax ASA: Invitation to first quarter 2018 results presentation Thursday 3 May

April 12, 2018

Press release - Regulatory

Targovax strengthens Board of Directors with the appointment of Catherine Wheeler

April 11, 2018

Press release - Regulatory

Targovax ASA: Protocol from the Annual General Meeting

March 24, 2018

Press release - Regulatory

Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018

March 15, 2018

Press release - Regulatory

Targovax ASA: Notice of Annual General Meeting

March 15, 2018

Press release - Regulatory

Targovax ASA: Annual Report 2017

March 1, 2018

Press release - Regulatory

Targovax ASA: Issuance of restricted stock unites (RSUs) to the chairman of the board of directors

February 27, 2018

Press release - Non-regulatory

Targovax to present at Biologics World Nordic 2018

February 15, 2018

Press release - Regulatory

Targovax ASA: Fourth quarter and full year 2017 results

February 7, 2018

Press release - Regulatory

Targovax announces completion of safety lead-in and preliminary immune activation data in ONCOS-102 trial in mesothelioma

February 6, 2018

Press release - Regulatory

Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February

February 2, 2018

Press release - Regulatory

Targovax ASA: Exercise price of options

February 1, 2018

Press release - Regulatory

Targovax ASA issues options to employees

January 8, 2018

Press release - Regulatory

Targovax announces the appointment of Michael Bogenstaetter as Chief Business Officer

January 4, 2018

Press release - Regulatory

Targovax announces that ONCOS-102 generates immune activation in checkpoint inhibitor refractory melanoma patients

December 18, 2017

Press release - Regulatory

Targovax announces that TG02 has passed the initial safety review in the first-in-man clinical trial in colorectal cancer

December 13, 2017

Press release - Non-regulatory

Targovax to present at DNB healthcare conference

December 11, 2017

Press release - Regulatory

Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews

November 30, 2017

Press release - Regulatory

Targovax ASA: New member of the board of directors

November 14, 2017

Press release - Regulatory

Targovax to present at upcoming investor conferences

November 7, 2017

Press release - Regulatory

Targovax ASA: Notice of Extraordinary General Meeting

November 3, 2017

Press release - Regulatory

Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

November 2, 2017

Press release - Regulatory

Targovax ASA: Third quarter 2017 results

October 27, 2017

Press release - Regulatory

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

October 24, 2017

Press release - Regulatory

Targovax ASA: Invitation to third quarter 2017 results presentation Thursday 2 November

October 12, 2017

Press release - Regulatory

Targovax announces one-year survival rate and safety data in the modified cohort of the TG01 trial in resected pancreatic cancer

October 3, 2017

Press release - Regulatory

Targovax granted US Patent for mutant-RAS neoantigen platform 2nd generation product TG02

September 25, 2017

Press release - Regulatory

Targovax granted US Patent for mutant-RAS neoantigen platform lead products

September 14, 2017

Press release - Regulatory

Targovax Receives 2017 Nordic Stars Award

September 12, 2017

Press release - Regulatory

Targovax announces start of patient recruitment in phase I/II study with ONCOS-102 in combination with durvalumab in patients with advanced peritoneal malignancies

September 11, 2017

Press release - Non-regulatory

Targovax ASA: Three posters presented at ESMO conference

August 29, 2017

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

August 28, 2017

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs

August 25, 2017

Press release - Regulatory

Exercise of employee share options and restricted stock units in Targovax ASA

August 24, 2017

Press release - Regulatory

Targovax ASA: Second quarter and first half 2017 results

August 23, 2017

Press release - Non-regulatory

Targovax ASA: Abstracts accepted for poster presentation at the ESMO 2017 Congress

August 18, 2017

Press release - Regulatory

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

August 14, 2017

Press release - Regulatory

Targovax ASA: Invitation to second quarter and first half 2017 results presentation Thursday 24 August

July 17, 2017

Press release - Regulatory

Targovax ASA: Final result of the subsequent offering

July 14, 2017

Press release - Regulatory

Targovax ASA: Preliminary result of the subsequent offering

July 14, 2017

Press release - Regulatory

Targovax ASA: Last day of the subscription period in the subsequent offering

July 7, 2017

Press release - Regulatory

Targovax ASA: Notification of trade by primary insiders

July 6, 2017

Press release - Regulatory

Targovax ASA: Registration of share capital increase following the private placement

July 3, 2017

Press release - Regulatory

Targovax ASA: Commencement of subscription period for the subsequent offering

June 30, 2017

Press release - Regulatory

Targovax ASA: Approval and publication of prospectus; the subsequent offering

June 30, 2017

Press release - Regulatory

Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

June 26, 2017

Press release - Regulatory

Targovax ASA: Registration of capital increase following exercise of employee options and settlement of restricted stock units

June 22, 2017

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in relation to exercise of employee options

June 22, 2017

Press release - Regulatory

Targovax ASA: Exercise of employee share options and settlement of restricted stock units in Targovax ASA

June 15, 2017

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of vested restricted stock units

June 14, 2017

Press release - Regulatory

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

June 9, 2017

Press release - Regulatory

Targovax ASA: Notice of Extraordinary General Meeting

June 9, 2017

Press release - Regulatory

Targovax ASA – Information on the subsequent offering – Key date information

June 8, 2017

Press release - Regulatory

TARGOVAX ASA – SUCCESSFULLY COMPLETED PRIVATE PLACEMENT

June 8, 2017

Press release - Regulatory

TARGOVAX ASA – CONTEMPLATED PRIVATE PLACEMENT

June 6, 2017

Press release - Regulatory

Targovax presents further positive clinical data from TG01 phase I/II trial at 2017 ASCO annual meeting

June 6, 2017

Press release - Regulatory

Targovax announces formal agenda for 2017 Capital Markets Updates in Oslo and London

May 18, 2017

Press release - Regulatory

Targovax ASA: ASCO abstract released

May 10, 2017

Press release - Regulatory

Targovax recruits first patient into first ONCOS-102 /Checkpoint inhibitor melanoma study

May 8, 2017

Press release - Regulatory

Targovax ASA: Capital Markets Updates in Oslo on Thursday 8 June and in London on Monday 26 June 2017

April 28, 2017

Press release - Regulatory

Targovax ASA: Issuance of restricted stock unites (RSUs) to the board members

April 25, 2017

Press release - Regulatory

Targovax ASA: First quarter 2017 results

April 20, 2017

Press release - Regulatory

Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform

April 19, 2017

Press release - Regulatory

Targovax ASA: Invitation to first quarter 2017 results presentation Tuesday 25 April

April 6, 2017

Press release - Regulatory

Targovax to present clinical data on its phase I/II clinical trial evaluating TG01 in resected pancreatic cancer at the ASCO Annual Meeting

April 5, 2017

Press release - Regulatory

Targovax ASA: Protocol from the Annual General Meeting

April 4, 2017

Press release - Regulatory

Targovax ASA: Proposal from the nomination committee to the annual general meeting 5 April 2017

April 4, 2017

Press release - Regulatory

Targovax ASA: Grant of share options

March 23, 2017

Press release - Regulatory

Targovax ASA moves share listing to Oslo Børs

March 22, 2017

Press release - Regulatory

Targovax ASA: Approval and publication listing prospectus

March 22, 2017

Press release - Regulatory

Targovax ASA: The board of directors of Oslo Stock Exchange approves transfer of Targovax ASA to the main list

March 17, 2017

Press release - Regulatory

Targovax ASA applies for transfer to Oslo Stock Exchange main list

March 15, 2017

Press release - Regulatory

Targovax ASA: Notice of Annual General Meeting

March 15, 2017

Press release - Regulatory

Targovax ASA: Annual Report 2016

March 6, 2017

Press release - Non-regulatory

Targovax to present at upcoming conferences

February 24, 2017

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options and settlement of restricted stock units

February 24, 2017

Press release - Regulatory

Targovax ASA: Exercise of employee share options and restricted stock units in Targovax ASA

February 16, 2017

Press release - Regulatory

Targovax ASA: Fourth quarter and full year 2016 results

February 13, 2017

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of restricted stock units

February 10, 2017

Press release - Regulatory

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

February 6, 2017

Press release - Regulatory

Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February

February 2, 2017

Press release - Regulatory

Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients

January 5, 2017

Press release - Regulatory

Targovax announces appointment of Erik Digman Wiklund as CFO

December 13, 2016

Press release - Non-regulatory

Targovax to present at DNB healthcare conference

December 9, 2016

Press release - Regulatory

Targovax ASA: Grant of share options

November 21, 2016

Press release - Regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options

November 21, 2016

Press release - Regulatory

Targovax ASA: Exercise of employee share options in Targovax ASA

November 18, 2016

Press release - Regulatory

Targovax ASA: Mandatory notification of trade by primary insider

November 17, 2016

Press release - Regulatory

Targovax ASA: Third quarter 2016 results

November 16, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conference

November 10, 2016

Press release - Regulatory

Targovax granted European Patent for ONCOS platform lead product, ONCOS-102

November 8, 2016

Press release - Regulatory

Targovax ASA: Invitation to third quarter 2016 results presentation Thursday 17 November

November 4, 2016

Press release - Regulatory

Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

November 2, 2016

Press release - Non-regulatory

Targovax ASA: GRANT OF SHARE OPTIONS

November 2, 2016

Press release - Non-regulatory

Targovax ASA: GRANT OF SHARE OPTIONS

November 2, 2016

Press release - Non-regulatory

Targovax announces appointment of Oystein Soug as CEO

October 21, 2016

Press release - Non-regulatory

Targovax presents ONCOS-102 scientific rationale at the European Society of Gene and Cell Therapy

October 17, 2016

Press release - Non-regulatory

Targovax to Present at the ESGCT/ISSCR Stem Cells & Gene Therapy Symposium

September 19, 2016

Press release - Non-regulatory

Targovax to present at Redeye’s Fight Cancer conference

September 14, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conferences

August 25, 2016

Press release - Regulatory

Targovax ASA: Interim Report second quarter and first half year 2016

August 17, 2016

Press release - Non-regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

August 17, 2016

Press release - Non-regulatory

Targovax ASA: Completion of subsequent offering, registration of share capital increase

August 15, 2016

Press release - Regulatory

Targovax ASA: Invitation to second quarter 2016 results presentation Thursday 25 August

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Allocations to primary insiders in the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Result of the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Allocations to primary insiders in the subsequent offering

August 9, 2016

Press release - Non-regulatory

Targovax ASA: Result of the subsequent offering

August 8, 2016

Press release - Non-regulatory

Targovax ASA – Last day of the subscription period in the subsequent offering

August 8, 2016

Press release - Non-regulatory

Targovax ASA – Last day of the subscription period in the subsequent offering

August 4, 2016

Press release - Non-regulatory

Anne-Sophie Møller joins Targovax

August 4, 2016

Press release - Non-regulatory

Anne-Sophie Møller joins Targovax

August 4, 2016

Press release - Non-regulatory

Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

August 4, 2016

Press release - Non-regulatory

Targovax ASA – The subscription period in the subsequent offering expires on Monday 8 August at 16:30 CET

July 11, 2016

Press release - Non-regulatory

Targovax ASA: Commencement of subscription period for the subsequent offering

July 8, 2016

Press release - Non-regulatory

Targovax ASA: Publication of prospectus, listing on Oslo Axess and subsequent offering

July 7, 2016

Press release - Non-regulatory

Targovax ASA: Completion of private placement, registration of share capital increase

July 6, 2016

Press release - Non-regulatory

Targovax ASA: Extraordinary general meeting held, approval of private placement and subsequent offering

July 6, 2016

Press release - Regulatory

Targovax presents encouraging preclinical data on ONCOS-102

July 1, 2016

Press release - Non-regulatory

Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

July 1, 2016

Press release - Regulatory

Targovax recruits the first patient in a trial with the oncolytic virus ONCOS-102 in malignant pleural mesothelioma

June 22, 2016

Press release - Non-regulatory

Notice of Extraordinary General Meeting

June 22, 2016

Press release - Non-regulatory

Targovax ASA: Announcement of successful NOK 110 million private placement

June 21, 2016

Press release - Non-regulatory

Targovax ASA: Update on bookbuilding for the private placement of NOK 100 – 130 million

June 20, 2016

Press release - Non-regulatory

Targovax ASA: Contemplated private placement of NOK 100 – 130 million

June 14, 2016

Press release - Regulatory

Targovax granted US Patent for oncolytic virus ONCOS-102

June 9, 2016

Press release - Regulatory

Targovax receives regulatory approval in Spain to conduct a clinical trial with its oncolytic virus ONCOS-102

June 7, 2016

Press release - Regulatory

Targovax ASA: Patient recruitment for TG01 immuno-oncology trial completed

June 2, 2016

Press release - Regulatory

Targovax receives approval in Australia to conduct a clinical trial with TG02 – an immunotheraphy treatment targeting RAS mutations

May 31, 2016

Press release - Non-regulatory

Targovax to present at forthcoming conferences

May 20, 2016

Press release - Non-regulatory

Magnus Jaderberg, CMO of Targovax, has presented at a symposium by The Royal Swedish Academy of Engineering Sciences

May 12, 2016

Press release - Regulatory

Targovax ASA: Interim report first quarter 2016

May 9, 2016

Press release - Regulatory

Targovax to present at BioEquity Europe and its first quarter 2016 results on May 11 – 12, 2016

May 9, 2016

Press release - Non-regulatory

Targovax ASA: Registration of share capital increase following exercise of employee options

April 29, 2016

Press release - Non-regulatory

Exercise of employee share options in Targovax ASA

April 16, 2016

Press release - Non-regulatory

Annual Report 2015

April 15, 2016

Press release - Non-regulatory

Targovax ASA: Grant of restricted stock units to the Board of directors

April 14, 2016

Press release - Regulatory

Targovax reports immune response with reduced number of TG01 vaccinations

April 14, 2016

Press release - Non-regulatory

Resolution to increase the share capital in Targovax ASA in relation to exercise of employee options

March 15, 2016

Press release - Non-regulatory

Targovax to present at forthcoming Life Science and Investor conferences

March 14, 2016

Press release - Regulatory

Targovax to present at forthcoming Life Science and Investor conferences

March 14, 2016

Press release - Non-regulatory

Sachs Zürich March 2016

March 11, 2016

Press release - Non-regulatory

Targovax in Dagens Medisin

March 10, 2016

Press release - Regulatory

Targovax announces encouraging interim results with RAS specific peptide vaccine in resected pancreatic cancer

March 7, 2016

Press release - Non-regulatory

Targovax in BioCentury cover story

March 2, 2016

Press release - Regulatory

Targovax ASA: Interim report fourth quarter 2015

February 25, 2016

Press release - Regulatory

CORRECTION: Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

February 25, 2016

Press release - Regulatory

Targovax ASA: Invitation to Fourth Quarter 2015 Results Presentation

February 2, 2016

Press release - Regulatory

Targovax submits a study of its adenovirus based immune therapy ONCOS-102 to the regulatory authorities in Spain

December 14, 2015

Press release - Non-regulatory

DNB’s 6th Annual Health Care Conference, Oslo, 15 December 2015

December 9, 2015

Press release - Non-regulatory

Exercise of employee share options

November 26, 2015

Press release - Regulatory

Targovax ASA: Interim report third quarter 2015

November 19, 2015

Press release - Regulatory

Targovax ASA: Invitation to presentation of Targovax’ third quarter 2015 results

November 18, 2015

Press release - Regulatory

Targovax ASA: LUDWIG CANCER RESEARCH AND CANCER RESEARCH INSTITUTE PARTNER WITH TARGOVAX TO TEST CANDIDATE VIROTHERAPY IN EARLY-PHASE CLINICAL TRIALS

November 6, 2015

Press release - Regulatory

Targovax to present at upcoming investor Conferences

November 5, 2015

Press release - Regulatory

Targovax ASA: Immunotherapy with ONCOS-102 show potential to activate immunologically silent tumors and reduce local immune suppression in advanced tumors

September 14, 2015

Press release - Non-regulatory

Protocol from Extraordinary General Meeting

September 14, 2015

Press release - Non-regulatory

Targovax appoints two new directors to its board

August 28, 2015

Press release - Non-regulatory

Targovax AS: Interim Report Q2 and 1H 2015

August 27, 2015

Press release - Non-regulatory

Notice of Extraordinary General Meeting

July 9, 2015

Press release - Non-regulatory

Completion of NOK 200 million private placement

July 2, 2015

Press release - Non-regulatory

Targovax AS: Closing of the acquisition of Oncos Therapeutics Oy

June 22, 2015

Press release - Non-regulatory

Protocol from general Meeting

June 18, 2015

Press release - Non-regulatory

Targovax announces successful NOK 200 million private placement

June 15, 2015

Press release - Non-regulatory

Targovax increases size of private placement to NOK 200 million after strong investor demand

June 11, 2015

Press release - Non-regulatory

Notice of Extraordinary General Meeting

June 11, 2015

Press release - Non-regulatory

Targovax and Oncos Therapeutics join forces to create a Nordic leader within immuno-oncology

June 2, 2015

Press release - Non-regulatory

ASCO poster 2015

June 1, 2015

Press release - Non-regulatory

Targovax presented safety data and immunological results at the 2015 ASCO Annual Meeting

May 18, 2015

Press release - Non-regulatory

Targovax presents data at ASCO 2015 in Chicago

May 12, 2015

Press release - Non-regulatory

Targovax AS: Interim Report Q1 2015

May 7, 2015

Press release - Non-regulatory

MEET US: Bio-International, Philadephia, June 14-18 2015

May 7, 2015

Press release - Non-regulatory

MEET US: ASCO, Chicago, June 1-3 2015

April 28, 2015

Press release - Non-regulatory

Protocol from general Meeting

April 20, 2015

Press release - Non-regulatory

Notice of general assembly

April 20, 2015

Press release - Non-regulatory

Targovax ASA: Oncos Therapeutics presenting at the Anglonordic Life Science Conference on April 23rd in London, UK.

April 17, 2015

Press release - Regulatory

Annual report 2014 – IFRS

April 16, 2015

Press release - Regulatory

Annual report 2014 – NGAAP

April 13, 2015

Press release - Non-regulatory

Targovax has appointed Peter Skorpil as Head of Business Development, effective from April 8th, 2015.

April 1, 2015

Press release - Non-regulatory

Targovax Presentation Arctic Biotech Seminar March 2015

March 9, 2015

Press release - Non-regulatory

Targovax has decided to expand the on-going phase I/II clinical study CT-TG01-01 with a new group of up to 13 patients.

February 26, 2015

Press release - Non-regulatory

Targovax ASA: Oncos represented at the 8th Annual Life Science CEO Forum & Exhibition March 3rd, 2015 in Zurich, Switzerland

February 26, 2015

Press release - Non-regulatory

Targovax is pleased to announce Mr. Øystein Soug as the new CFO of the Company from June 1, 2015

February 16, 2015

Press release - Non-regulatory

Interim Report Q4 and YTD 2014

February 11, 2015

Press release - Non-regulatory

Protocol from general Meeting

February 3, 2015

Press release - Non-regulatory

Notice of Extraordinary General Meeting

January 26, 2015

Press release - Non-regulatory

Targovax ASA: ONCOS-102 Mechanism of Action -video released on the website

January 22, 2015

Press release - Non-regulatory

Targovax strengthens management team

January 12, 2015

Press release - Non-regulatory

Targovax ASA: ONCOS-102 granted US lung cancer orphan drug designation

January 8, 2015

Press release - Non-regulatory

Targovax reports completion of recruitment of patients in the phase I/II clinical trial CT TG01-01

December 31, 2014

Press release - Non-regulatory

Targovax AS: Interim Report Q4 and YTD 2014

December 17, 2014

Press release - Non-regulatory

Targovax ASA: “ONCOS-102 sensitizes tumors to other immunotherapies” – Paper published in the latest issue of OncoImmunology

December 1, 2014

Press release - Non-regulatory

Targovax awarded an immuno-oncology innovation prize

November 25, 2014

Press release - Non-regulatory

Targovax ASA: Oncos Therapeutics receives a positive opinion on orphan drug designation for ONCOS-102

November 21, 2014

Press release - Non-regulatory

Targovax AS: Interim Report Q3 and YTD 2014

November 20, 2014

Press release - Non-regulatory

Targovax ASA: Oncos presented a poster at EORTC-NCI-AACR Meeting 2014

November 10, 2014

Press release - Non-regulatory

Targovax ASA: Oncos presented a poster at the SITC Annual Meeting 2014

November 5, 2014

Press release - Non-regulatory

Targovax ASA: Sari Pesonen invited to present a poster at EORTC-NCI-AACR 2014, Nov 18-21, in Barcelona

November 5, 2014

Press release - Non-regulatory

Targovax ASA: Frans Wuite invited to be a panelist in European Business Angel on Nov 17

November 5, 2014

Press release - Non-regulatory

MEET US: DNB Markets Health Care Conference 2014, December 11th 2014, Oslo, Norway

November 3, 2014

Press release - Non-regulatory

Targovax AS has reached primary endpoint for the ongoing phase I/II clinical trial CT TG01-01

November 3, 2014

Press release - Non-regulatory

Targovax AS has reached an important milestone

October 30, 2014

Press release - Non-regulatory

Targovax ASA: Frans Wuite presenting Oncos at Bio Europe 2014 on Nov 5, 2014 in Frankfurt

October 30, 2014

Press release - Non-regulatory

Protocol from general assembly

October 27, 2014

Press release - Non-regulatory

Targovax ASA: Oncos presenting at the fall seminar of Statisticians in Finnish Pharmaceutical Industry held in Turku, Finland Oct 30, 2014

October 23, 2014

Press release - Non-regulatory

Notice of general assembly

October 8, 2014

Press release - Non-regulatory

Targovax ASA:

October 3, 2014

Press release - Non-regulatory

Targovax appoints Gunnar Gårdemyr as new CEO

October 1, 2014

Press release - Non-regulatory

Targovax Presentation Arctic Biotech Day September 2014

September 11, 2014

Press release - Non-regulatory

New member of the Board

September 11, 2014

Press release - Non-regulatory

Protocol from general assembly

September 3, 2014

Press release - Non-regulatory

Notice of general assembly

September 2, 2014

Press release - Non-regulatory

Notice of general assembly

August 27, 2014

Press release - Non-regulatory

Targovax: Interim Report Q2 and YTD 2014

June 16, 2014

Press release - Non-regulatory

Targovax AS is registered on the NOTC-list

June 4, 2014

Press release - Non-regulatory

Targovax ASA: Oncos Therapeutics recruits Dr Magnus Jaderberg as CMO to strengthen its focus on cancer immunotherapy

June 4, 2014

Press release - Non-regulatory

Targovax successfully completes a 70 MNOK financing

June 2, 2014

Press release - Non-regulatory

Oncos Therapeutics granted US and EU Orphan Drug Designation for ONCOS-102 in ovarian cancer

May 8, 2014

Press release - Non-regulatory

Targovax ASA: ONCOS – achievement in cancer immunotherapy – PRESS RELEASE

April 4, 2014

Press release - Non-regulatory

Targovax in Dagens Medisin

April 1, 2014

Press release - Non-regulatory

MEET US: CIMT, Mainz, May 6-8th

February 28, 2014

Press release - Non-regulatory

Targovax ASA: ATMP classification for ONCOS-102 by European Medicines Agency

February 6, 2014

Press release - Non-regulatory

MEET US: BIO-Europe Spring, 2014

February 6, 2014

Press release - Non-regulatory

Targovax TG01 immunotherapy reaches phase IIA in operable pancreatic cancer

January 31, 2014

Press release - Non-regulatory

Targovax ASA: Oncos Therapeutics among Top 20 Finnish startup companies by Talouselämä journal

October 15, 2013

Press release - Non-regulatory

Oncos Therapeutics nominated the Nordic Star Finland by SwedenBIO

September 15, 2013

Press release - Non-regulatory

Professor Hani Gabra joins Clinical Advisory Board of Oncos Therapeutics

July 31, 2013

Press release - Non-regulatory

Oncos Therapeutics granted Orphan Drug Designation for CGTG-102 by FDA and EMA

June 21, 2013

Press release - Non-regulatory

Oncos Therapeutics nominated again among the most promising startup companies

May 29, 2013

Press release - Non-regulatory

Targovax receives 20 MNOK in private and public support

January 29, 2013

Press release - Non-regulatory

First patient included in phase I/II clinical study with TG01 in operable pancreatic cancer

November 14, 2012

Press release - Non-regulatory

Oncos Therapeutics appoints experienced industry leader Frans Wuite as President and CEO

November 1, 2012

Press release - Non-regulatory

TG01 getting ready for phase I/II

July 5, 2012

Press release - Non-regulatory

Oncos Therapeutics Announces Clinical Advisory Board

May 29, 2012

Press release - Non-regulatory

Oncos Therapeutics successfully initiates Phase I clinical study

March 14, 2012

Press release - Non-regulatory

Patient recruitment started in C1 study in Finland (in Finnish)

January 25, 2012

Press release - Non-regulatory

Secures 13 MNOK for development of pancreas cancer vaccine TG01

November 28, 2011

Press release - Non-regulatory

9 million NOK for development of cancer vaccine

June 13, 2011

Press release - Non-regulatory

Targovax AS received a grant from Innovation Norway